GENEVA, March 4 -- ERASCA, INC. (3115 Merryfield Row, Suite 300San Diego, California 92121) filed a patent application (PCT/US2025/042860) for "RAS AND PRMT5 INHIBITORS COMBINATION THERAPY" on Aug 20, 2025. With publication no. WO/2026/044042, the details related to the patent application was published on Feb 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): SHOEMAKER, Robert Field (c/o Erasca, Inc.3115 Merryfield Row, Suite 300San Diego, California 92121), BROOUN, Alexei (c/o Erasca, Inc.3115 Merryfield Row, Suite 300San Diego, California 92121), BAE, Jae Hyun (c/o Erasca, Inc.3115 Merryf...